Similar to DCP 2 (CDER)

406B - Section of the FDA Modernization Act dealing with getting feedback from our stakeholders
505(b)(2) - A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference.
510(k) - Food, Drug, and Cosmetic Act Section 501k, Pre-Market Notification
A-V - ArterioVenous
A-VO2 - ArterioVenous Oxygen
A/L - Annual Leave
A2LA - American Association for Laboratory Accreditation

View all in FDA